Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Addiction Medicine
Preventive Medicine Associates in Massachusetts to offer Hythiam's Prometa protocols
October 25th, 2006
Hythiam, Inc., (HYTM), a healthcare services management company that licenses the Prometa treatment protocols designed to treat alcohol, methamphetamine, and cocaine dependence, announced that the Prometa protocols have been licensed for use initially at up to four locations of the largest outpatient substance dependence providers in Massachusetts, Preventive Medicine Associates (PMA). PMA operates 17 facilities in Massachusetts that all treat addictive disorders. Each year, PMA treats 12,000 unique patients for substance dependencies among its network of addiction medicine providers with 36,000 patient visits per year. "We are...
Source: Biotech Week (2006-10-25)
|
